FDA issued a Warning Letter to Shilpa Medicare Limited on 10/9/2020 as a result of this inspection.
483 Shilpa Medicare Feb 2020

483 Shilpa Medicare Feb 2020

Miguel Martinez FDA, Jose Melendez FDA$119.00 - Available Now

FDA investigators audited the Shilpa Medicare - Polepally, Jadcherla, India facility and issued inspectional observations (via FDA 483) on 25 Feb 2020.

Product details

  • Category: Human Drugs
  • Inspection end: 25 Feb 2020
  • Location: Polepally, Jadcherla, India
  • FEI: 3009876430
Add To Cart